This compound is a modified uridine phosphoramidite designed for automated oligonucleotide synthesis. It features a dimethoxytrityl (DMTr) protecting group, a 2'-O-docosyl (C22) modification, and a 3'-cyanoethyl phosphoramidite moiety.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2923115-86-8
2'-O-Hexadecyl-U-CE-Phosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-propyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
RNA synthesis building block
Methyl 16-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-2-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-3-yl]oxyhexadecanoate
phosphoramidite building block for oligonucleotide synthesis
2'-propargyl U amidite
RNA synthesis phosphoramidite building block
5'(E)-VP-2 inverted exclamation mark -F-U-CE-Phoshoramidite
Nucleotide phosphoramidite building block
3-Desethyl-3-(2-aminoethyl) aminoethoxy Amlodipine
amlodipine impurity reference standard
(2-fluorophenyl)hydrazine Hydrochloride
Pharmaceutical raw material
5-bromo-6-chloropyridine-3-carboxylic acid
Pharmaceutical intermediate for synthesis
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-docosoxyoxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
UVVBAOHROLTNIE-PGNDMMQRSA-N
CCCCCCCCCCCCCCCCCCCCCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N
—